Monday, February 25, 2008

Barr Pharmaceuticals Inc. subsidiary, Duramed Pharmaceuticals Inc., files lawsuit

Barr Pharmaceuticals Inc. subsidiary, Duramed Pharmaceuticals Inc., files litigation against Watson Pharmaceuticals.

"Watson Pharmaceuticals (NYSE:WPI) Inc. said Friday that Duramed Pharmaceuticals Inc., a subsidiary of Barr Pharmaceuticals Inc. (NYSE:BRL) , filed a patent lawsuit against Watson and certain of its subsidiaries related to Quasense, Watson's generic version of Duramed's Seasonale, an extended-cycle oral contraceptive."

Source

Wednesday, February 06, 2008

Barr Pharmaceuticals Inc. confirms lawsuit

Barr Pharmaceuticals Inc., maker of generic drugs, confirms litigation against Encysive
"Generic drug maker Barr Pharmaceuticals Inc. (NYSE:BRL) on Wednesday confirmed it is challenging a patent held by biopharmaceutical company Encysive Pharmaceuticals Inc. (NASDAQ:ENCY) for blood-clotting injection Argatroban.

Argatroban is approved by the Food and Drug Administration for the treatment of heparin-induced thrombocytopenia, a serious side effect of the blood thinner heparin."
 


Looking for last minute shopping deals? Find them fast with Yahoo! Search.